United States: Strategizing To Operationalize The Medicare Advantage And Part D Final Rule

More than a year ago, the U.S. Centers for Medicare & Medicaid Services (CMS) proposed significant regulatory changes to the Medicare Advantage (MA) and Part D Programs, many of which were the subject of significant controversy.  With the issuance of its February 12, 2015 final rule (2015 Final Rule), CMS has now finalized or withdrawn all of the proposals set forth in its January 10, 2014 proposed rule.  The provisions in the 2015 Final Rule will be effective for contract year (CY) 2016, so MA Organizations (MAOs) and Part D Plan Sponsors will have a few months to undertake their strategic analyses and determine which contracts may require modification, the system updates that should be confirmed with vendors, and other operational considerations as part of CY 2016 preparations.

Multi-Phase Rulemaking Process Results in Many Withdrawn Proposals

CMS initially finalized or withdrew numerous proposals in its May 23, 2014 final rule.  Among the controversial proposals withdrawn were the provisions to limit sponsors of stand-alone Prescription Drug Plans to only two plans per region, to codify an interpretation of the Part D "non-interference" clause, to impose new requirements for preferred pharmacy networks and to modify criteria for the so-called "protected classes" of Part D drugs.  CMS has indicated that one or more of these issues may reappear in future rulemaking. 

Through the 2015 Final Rule, CMS has withdrawn several proposals for which final action was deferred in May 2014.  For example, CMS is not finalizing the proposal to terminate contracts under which an MAO offers Medicare Advantage-Prescription Drug (MA-PD) Plans for failure to achieve, over three consecutive years, three-star ratings for both Part C and Part D Quality Star Ratings.  (This proposal and its withdrawal has no effect on CMS's existing authority to terminate such contracts for failure to achieve, over three consecutive years, three-star ratings for Part C Quality Star Ratings or three-star ratings for Part D Quality Star Ratings).  CMS also has elected not to finalize its proposal prohibiting pharmacies that are related parties of Part D Plan Sponsors from waiving cost-sharing obligations for members enrolled in the related party's Part D Plans.  Although CMS did not finalize its proposal to require MAOs and Part D Plan Sponsors (Sponsors) to hire independent auditors to conduct program audits, CMS is moving forward with its proposal to require Sponsors to hire independent auditors to conduct validation audits to determine whether previously identified deficiencies have been corrected. 

Varying Effective Dates for Regulatory Changes

Although many proposals finalized in May 2014 applied to CY 2015, CMS delayed until January 1, 2016 the applicability of several finalized policies, such as the modified definition of the Part D "negotiated price" and the requirement that it include all price concessions from network pharmacies (except contingent amounts that cannot reasonably be determined at the point of sale).  Part D Plan Sponsors may want to confirm that their pharmacy benefit management (PBM) contracts—and PBM systems, policies and procedures—properly account for this regulatory change.  Similarly, Part D Plan Sponsors may want to confirm that their PBM contracts and PBM systems are prepared to comply with the existing pricing standard requirements that apply to maximum allowable cost (MAC) pricing standards beginning January 1, 2016.

The 2015 Final Rule finalizes a number of regulatory changes that also will apply in CY 2016 and therefore require some advance planning.  Examples include the following:

  • Part D Plan Sponsors might confer with their PBMs to determine whether modifications to contracts and/or claims adjudication systems are appropriate to account for the long-term care (LTC) pharmacy requirements, including the prohibition on payment arrangements that penalize "more efficient" LTC dispensing techniques.
  • MAOs offering MA-PD Plans may consider reaching out to their PBMs to confirm the preparation and implementation of coordinated policies and procedures so that the MAO can "coordinate all benefits administered by plan" for prescription drugs among Medicare Parts A, B and D under the new 42 C.F.R. § 422.112(b)(7).
  • Part D Plan Sponsors and their vendors will need to plan for distribution of the new Part D Annual Notices of Changes, which must be received by enrollees at least 15 days prior to the annual coordinated election period.  CMS in prior years has levied civil money penalties on numerous Sponsors that have failed to deliver timely and/or accurate Annual Notices of Change. 
  • CMS has removed the reference to "extraordinary circumstances" from the definition of "urgent services," thus making MAOs financially responsible for urgent services furnished by out-of-network providers in non-extraordinary circumstances but for which the MAOs' provider networks are temporarily unavailable or inaccessible.  MAOs may consider evaluating the scope of their provider networks, including service hours of contracted providers and availability of urgent care facilities, as a result of this new requirement.
  • Sponsors are required to have in place business continuity plans that "plan to restore essential functions within 72 hours after any of the essential functions fail or otherwise stop functioning as usual."  Sponsors that contract with administrative services providers, such as PBMs or call-center vendors, for one or more of these essential functions should assess the applicable contracts, policies and procedures, and business continuity plans of these vendors to ensure that the Sponsors will be able to satisfy CMS's new standards.

Later this week, CMS will issue the Advance Notice of Methodological Changes for Contract Year 2016 MA Capitation Rates, Part C and Part D Payment Policies, and is expected to issue the CY 2016 draft call letter as well.  These draft guidance documents may contain proposals that further implement some of these new requirements or address some of the issues for which CMS chose not to finalize a January 2014 proposal.  CMS has indicated, for example, that it may consider access requirements for preferred pharmacy networks based on studies CMS conducted in 2014, and include proposals in the draft call letter.  

Strategizing To Operationalize The Medicare Advantage And Part D Final Rule

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions